The GSEA pathway study revealed that METTL3 mainly regulates the cell cycle, renal cell carcinoma, and cancer pathways, which shed light on the METTL3 signaling mechanism in CRC. Here, METTL3 is linked to hereditary clear cell renal cell carcinoma.